Despite Strong Evidence, Hypofractionated Radiation Underused in the US
In recent years, hypofractionated radiation has become the preferred treatment for several cancer types, including early-stage breast, prostate, lung, and rectal cancers. This shift is based on mounting evidence that supports the efficacy and safety of regimens delivering higher doses of radiation in fewer sessions. Research shows that this approach is at least as effective […]